Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome

Cornerstone Pharmaceuticals · 2016
ClinicalTrials.gov · Datasets · License: Public Domain · 2016
Open Source ↗
acute-myeloid-leukemia
acute myeloid leukemia (aml), myelodysplastic syndrome (mds), acute myeloid leukemia, myelodysplastic syndrome, refractory, relapsed, hypomethylating agents, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 886703
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.